-
-
-
-
-
-
-
MERGER ALERT - CIT and BSTC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
-
-
-
-
-
-
-
Biospecifics Technologies (BSTC) Appoints Joseph Truitt as Interim CEO
-
-
-
-
-
-
-
BioSpecifics Technologies Corp. Announces First Commercial Sale of XIAFLEX® for the Treatment of Dupuytren's Contracture in Japan
-
-
-
-
-
-
-
BioSpecifics Technologies Corp. to Present at the Jefferies 2015 Healthcare Conference
-
-
-
-
-
-
-
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2014 Financial Results
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

